Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 200 shares, a growth of 100.0% from the March 15th total of 100 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 5,400 shares, the short-interest ratio is presently 0.0 days.
Fidelity Disruptive Medicine ETF Stock Performance
Shares of NASDAQ:FMED traded down $0.11 during trading on Wednesday, reaching $22.86. The company had a trading volume of 4,091 shares, compared to its average volume of 5,384. Fidelity Disruptive Medicine ETF has a twelve month low of $20.69 and a twelve month high of $26.79. The firm has a market capitalization of $48.01 million, a PE ratio of 39.96 and a beta of 0.94. The firm’s fifty day moving average is $24.30 and its 200 day moving average is $25.25.
Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF
A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC increased its stake in Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Free Report) by 200.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,342 shares of the company’s stock after purchasing an additional 40,924 shares during the quarter. Jane Street Group LLC owned approximately 2.92% of Fidelity Disruptive Medicine ETF worth $1,613,000 as of its most recent filing with the Securities and Exchange Commission.
About Fidelity Disruptive Medicine ETF
The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.
See Also
- Five stocks we like better than Fidelity Disruptive Medicine ETF
- What does consumer price index measure?
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- What is the S&P 500 and How It is Distinct from Other Indexes
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Why Invest in 5G? How to Invest in 5G Stocks
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Fidelity Disruptive Medicine ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Disruptive Medicine ETF and related companies with MarketBeat.com's FREE daily email newsletter.
